QUANEX BUILDING PRODUCTS (NX) Fundamental Analysis & Valuation

NYSE:NX • US7476191041

Current stock price

17.61 USD
+0.35 (+2.03%)
Last:

This NX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. NX Profitability Analysis

1.1 Basic Checks

  • In the past year NX was profitable.
  • In the past year NX had a positive cash flow from operations.
  • NX had positive earnings in 4 of the past 5 years.
  • In the past 5 years NX always reported a positive cash flow from operatings.
NX Yearly Net Income VS EBIT VS OCF VS FCFNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • NX has a worse Return On Assets (-12.13%) than 78.57% of its industry peers.
  • NX has a Return On Equity of -32.86%. This is in the lower half of the industry: NX underperforms 76.19% of its industry peers.
  • The Return On Invested Capital of NX (5.46%) is worse than 66.67% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NX is significantly below the industry average of 11.89%.
Industry RankSector Rank
ROA -12.13%
ROE -32.86%
ROIC 5.46%
ROA(3y)-0.46%
ROA(5y)3.75%
ROE(3y)-5.38%
ROE(5y)3.29%
ROIC(3y)6.69%
ROIC(5y)9.3%
NX Yearly ROA, ROE, ROICNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • With a Operating Margin value of 6.52%, NX is not doing good in the industry: 61.90% of the companies in the same industry are doing better.
  • NX's Operating Margin has been stable in the last couple of years.
  • The Gross Margin of NX (27.37%) is comparable to the rest of the industry.
  • NX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.52%
PM (TTM) N/A
GM 27.37%
OM growth 3Y-10.87%
OM growth 5Y-0.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y3.71%
NX Yearly Profit, Operating, Gross MarginsNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. NX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NX is destroying value.
  • Compared to 1 year ago, NX has less shares outstanding
  • Compared to 5 years ago, NX has more shares outstanding
  • Compared to 1 year ago, NX has a worse debt to assets ratio.
NX Yearly Shares OutstandingNX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
NX Yearly Total Debt VS Total AssetsNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • NX has an Altman-Z score of 1.82. This is not the best score and indicates that NX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of NX (1.82) is worse than 78.57% of its industry peers.
  • The Debt to FCF ratio of NX is 7.45, which is on the high side as it means it would take NX, 7.45 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of NX (7.45) is worse than 64.29% of its industry peers.
  • A Debt/Equity ratio of 0.93 indicates that NX is somewhat dependend on debt financing.
  • NX has a Debt to Equity ratio of 0.93. This is in the lower half of the industry: NX underperforms 69.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 7.45
Altman-Z 1.82
ROIC/WACC0.52
WACC10.45%
NX Yearly LT Debt VS Equity VS FCFNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • NX has a Current Ratio of 2.31. This indicates that NX is financially healthy and has no problem in meeting its short term obligations.
  • NX has a better Current ratio (2.31) than 61.90% of its industry peers.
  • NX has a Quick Ratio of 1.21. This is a normal value and indicates that NX is financially healthy and should not expect problems in meeting its short term obligations.
  • NX has a better Quick ratio (1.21) than 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.21
NX Yearly Current Assets VS Current LiabilitesNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. NX Growth Analysis

3.1 Past

  • The earnings per share for NX have decreased by -3.65% in the last year.
  • NX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.25% yearly.
  • Looking at the last year, NX shows a very strong growth in Revenue. The Revenue has grown by 28.35%.
  • The Revenue has been growing by 16.63% on average over the past years. This is quite good.
EPS 1Y (TTM)-3.65%
EPS 3Y-4.83%
EPS 5Y13.25%
EPS Q2Q%-105.26%
Revenue 1Y (TTM)28.35%
Revenue growth 3Y14.58%
Revenue growth 5Y16.63%
Sales Q2Q%2.26%

3.2 Future

  • NX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.82% yearly.
  • NX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.03% yearly.
EPS Next Y-6.48%
EPS Next 2Y3.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.3%
Revenue Next 2Y2.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NX Yearly Revenue VS EstimatesNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
NX Yearly EPS VS EstimatesNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. NX Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 8.35 indicates a reasonable valuation of NX.
  • Based on the Price/Earnings ratio, NX is valued cheaper than 100.00% of the companies in the same industry.
  • NX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.54.
  • A Price/Forward Earnings ratio of 7.07 indicates a rather cheap valuation of NX.
  • 100.00% of the companies in the same industry are more expensive than NX, based on the Price/Forward Earnings ratio.
  • NX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.35
Fwd PE 7.07
NX Price Earnings VS Forward Price EarningsNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • NX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NX is cheaper than 92.86% of the companies in the same industry.
  • NX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NX is cheaper than 97.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.52
EV/EBITDA 6.44
NX Per share dataNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.63
EPS Next 2Y3.82%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. NX Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.94%, NX has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.77, NX pays a better dividend. On top of this NX pays more dividend than 88.10% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, NX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.94%

5.2 History

  • The dividend of NX has a limited annual growth rate of 0.08%.
  • NX has paid a dividend for at least 10 years, which is a reliable track record.
  • NX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.08%
Div Incr Years0
Div Non Decr Years15
NX Yearly Dividends per shareNX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3

5.3 Sustainability

  • The earnings of NX are negative and hence is the payout ratio. NX will probably not be able to sustain this dividend level.
  • The dividend of NX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-6.13%
EPS Next 2Y3.82%
EPS Next 3YN/A
NX Yearly Income VS Free CF VS DividendNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

More info and screens

Find the best dividend stocksShow peers with best dividend

NX Fundamentals: All Metrics, Ratios and Statistics

QUANEX BUILDING PRODUCTS

NYSE:NX (3/24/2026, 1:10:25 PM)

17.61

+0.35 (+2.03%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)03-05
Earnings (Next)06-03
Inst Owners108.05%
Inst Owner Change3.44%
Ins Owners1.26%
Ins Owner Change10.95%
Market Cap808.83M
Revenue(TTM)1.85B
Net Income(TTM)-239.99M
Analysts86
Price Target28.56 (62.18%)
Short Float %3.9%
Short Ratio2.95
Dividend
Industry RankSector Rank
Dividend Yield 1.94%
Yearly Dividend0.32
Dividend Growth(5Y)0.08%
DP-6.13%
Div Incr Years0
Div Non Decr Years15
Ex-Date03-17
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)69.79%
Min EPS beat(2)56.47%
Max EPS beat(2)83.12%
EPS beat(4)3
Avg EPS beat(4)35.6%
Min EPS beat(4)-20.49%
Max EPS beat(4)83.12%
EPS beat(8)7
Avg EPS beat(8)494.92%
EPS beat(12)11
Avg EPS beat(12)346.29%
EPS beat(16)14
Avg EPS beat(16)266.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.54%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.82%
Min Revenue beat(4)-2.2%
Max Revenue beat(4)1.03%
Revenue beat(8)2
Avg Revenue beat(8)-1.03%
Revenue beat(12)4
Avg Revenue beat(12)-0.88%
Revenue beat(16)7
Avg Revenue beat(16)0.12%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-10.61%
EPS NQ rev (3m)-10.61%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)4.02%
Revenue NQ rev (3m)4.02%
Revenue NY rev (1m)1.05%
Revenue NY rev (3m)1.05%
Valuation
Industry RankSector Rank
PE 8.35
Fwd PE 7.07
P/S 0.44
P/FCF 8.52
P/OCF 5.15
P/B 1.11
P/tB N/A
EV/EBITDA 6.44
EPS(TTM)2.11
EY11.98%
EPS(NY)2.49
Fwd EY14.14%
FCF(TTM)2.07
FCFY11.73%
OCF(TTM)3.42
OCFY19.44%
SpS40.21
BVpS15.9
TBVpS-1.95
PEG (NY)N/A
PEG (5Y)0.63
Graham Number27.48
Profitability
Industry RankSector Rank
ROA -12.13%
ROE -32.86%
ROCE 6.95%
ROIC 5.46%
ROICexc 5.67%
ROICexgc 11.13%
OM 6.52%
PM (TTM) N/A
GM 27.37%
FCFM 5.14%
ROA(3y)-0.46%
ROA(5y)3.75%
ROE(3y)-5.38%
ROE(5y)3.29%
ROIC(3y)6.69%
ROIC(5y)9.3%
ROICexc(3y)7.19%
ROICexc(5y)10.09%
ROICexgc(3y)13.35%
ROICexgc(5y)17.83%
ROCE(3y)8.51%
ROCE(5y)11.84%
ROICexgc growth 3Y-23.91%
ROICexgc growth 5Y-6.21%
ROICexc growth 3Y-29.51%
ROICexc growth 5Y-7.67%
OM growth 3Y-10.87%
OM growth 5Y-0.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y3.71%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 7.45
Debt/EBITDA 3.04
Cap/Depr 60.52%
Cap/Sales 3.37%
Interest Coverage 250
Cash Conversion 70.37%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 1.21
Altman-Z 1.82
F-Score5
WACC10.45%
ROIC/WACC0.52
Cap/Depr(3y)69.75%
Cap/Depr(5y)69.6%
Cap/Sales(3y)3.21%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.65%
EPS 3Y-4.83%
EPS 5Y13.25%
EPS Q2Q%-105.26%
EPS Next Y-6.48%
EPS Next 2Y3.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.35%
Revenue growth 3Y14.58%
Revenue growth 5Y16.63%
Sales Q2Q%2.26%
Revenue Next Year2.3%
Revenue Next 2Y2.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y132.01%
EBIT growth 3Y2.12%
EBIT growth 5Y16.22%
EBIT Next Year37.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.45%
FCF growth 3Y16.4%
FCF growth 5Y6.37%
OCF growth 1Y6.38%
OCF growth 3Y18.95%
OCF growth 5Y10.34%

QUANEX BUILDING PRODUCTS / NX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for QUANEX BUILDING PRODUCTS?

ChartMill assigns a fundamental rating of 4 / 10 to NX.


Can you provide the valuation status for QUANEX BUILDING PRODUCTS?

ChartMill assigns a valuation rating of 7 / 10 to QUANEX BUILDING PRODUCTS (NX). This can be considered as Undervalued.


Can you provide the profitability details for QUANEX BUILDING PRODUCTS?

QUANEX BUILDING PRODUCTS (NX) has a profitability rating of 3 / 10.


How financially healthy is QUANEX BUILDING PRODUCTS?

The financial health rating of QUANEX BUILDING PRODUCTS (NX) is 3 / 10.


What is the earnings growth outlook for QUANEX BUILDING PRODUCTS?

The Earnings per Share (EPS) of QUANEX BUILDING PRODUCTS (NX) is expected to decline by -6.48% in the next year.